{"organizations": [], "uuid": "db6415a76a84b5df7dbaa3431d10766faa3d8559", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-gemphire-announces-initiation-of-p/brief-gemphire-announces-initiation-of-phase-2a-clinical-trial-of-pediatric-nafld-idUSASB0C3B8", "country": "US", "domain_rank": 408, "title": "BRIEF-Gemphire Announces Initiation Of Phase 2A Clinical Trial Of Pediatric NAFLD", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-31T23:52:00.000+02:00", "replies_count": 0, "uuid": "db6415a76a84b5df7dbaa3431d10766faa3d8559"}, "author": "", "url": "https://www.reuters.com/article/brief-gemphire-announces-initiation-of-p/brief-gemphire-announces-initiation-of-phase-2a-clinical-trial-of-pediatric-nafld-idUSASB0C3B8", "ord_in_thread": 0, "title": "BRIEF-Gemphire Announces Initiation Of Phase 2A Clinical Trial Of Pediatric NAFLD", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 31 (Reuters) - Gemphire Therapeutics Inc:\n* GEMPHIRE ANNOUNCES INITIATION OF PHASE 2A CLINICAL TRIAL OF GEMCABENE IN PEDIATRIC NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)\n* GEMPHIRE THERAPEUTICS INC - ‍TOP LINE RESULTS FROM PEDIATRIC NAFLD TRIAL ARE EXPECTED IN EARLY 2019​ Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-01-31T23:52:00.000+02:00", "crawled": "2018-02-01T00:08:08.019+02:00", "highlightTitle": ""}